Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:19 PM
Ignite Modification Date:
2025-12-24 @ 7:19 PM
NCT ID:
NCT01196403
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histopathologically confirmed bladder cancer, including any of the following cell types:
* Urothelial cell (transitional cell) carcinoma
* Squamous cell carcinoma
* Adenocarcinoma
* Stage pT1, pT2, or pT3 disease OR mobile bladder mass on bimanual examination under anesthesia
* No enlarged nodes or distant metastases on CT or MRI scan of the abdomen and pelvis
* No upper urinary tract disease
PATIENT CHARACTERISTICS:
* American Society of Anesthesiologist (ASA) status 1-3
* Life expectancy \> 24 months
* Not pregnant or nursing
* Negative pregnancy test
* No concurrent disease that would render the patient unsuitable for the trial
* No presence of urosepsis
PRIOR CONCURRENT THERAPY:
* May have received prior neoadjuvant chemotherapy provided study surgery is performed between 3 and 10 weeks from the date of the completion of chemotherapy treatment
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01196403
Study Brief:
Protocol Section:
NCT01196403